CRISPR Cuts https://crisprcuts.podbean.com Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science. Wed, 31 Jan 2024 00:01:00 -0800 https://podbean.com/?v=5.5 en us Copyright 2019 All rights reserved. Science:Life Sciences 1440 episodic Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science. Synthego Synthego No false https://pbcdn1.podbean.com/imglogo/image-logo/3332529/Crispr_Cuts.jpg CRISPR Cuts https://crisprcuts.podbean.com 144 144 Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology https://crisprcuts.podbean.com/e/imran-house-and-junyun-lai-discuss-crispr-screening-in-immuno-oncology/ https://crisprcuts.podbean.com/e/imran-house-and-junyun-lai-discuss-crispr-screening-in-immuno-oncology/#comments Wed, 31 Jan 2024 00:01:00 -0800 crisprcuts.podbean.com/ac8718fe-0c6b-3938-a730-ba2b21efb005 Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.

 

Reach out and connect with both Imran and Junyun on social media platforms:

Imran House, Ph.D.

LinkedIn

X: @ImranHouse

 

Junyun Lai, Ph.D.

LinkedIn

X: @JunyunLai

]]> Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.

 

Reach out and connect with both Imran and Junyun on social media platforms:

Imran House, Ph.D.

LinkedIn

X: @ImranHouse

 

Junyun Lai, Ph.D.

LinkedIn

X: @JunyunLai

]]> Synthego false No 1566 44 full Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia https://crisprcuts.podbean.com/e/mark-dewitt-and-don-kohn-discuss-their-ex-vivo-crispr-based-therapy-to-cure-sickle-cell-anemia/ https://crisprcuts.podbean.com/e/mark-dewitt-and-don-kohn-discuss-their-ex-vivo-crispr-based-therapy-to-cure-sickle-cell-anemia/#comments Fri, 20 Oct 2023 00:01:00 -0700 crisprcuts.podbean.com/9f520e41-a898-3a6f-8207-ed1eeecb8947 Dr. Mark DeWitt Ph.D., Associate Director at Mammoth Biosciences, and Dr. Don Kohn M.D., distinguished professor and Director of the UCLA Human Gene and Cell Therapy Program and CIRM grantee sat down with us to discuss their latest clinical trials to cure sickle cell anemia, how synthetic guides accelerated their journey from the bench to the clinic, and their experience in the cell and gene therapy space.

]]> Dr. Mark DeWitt Ph.D., Associate Director at Mammoth Biosciences, and Dr. Don Kohn M.D., distinguished professor and Director of the UCLA Human Gene and Cell Therapy Program and CIRM grantee sat down with us to discuss their latest clinical trials to cure sickle cell anemia, how synthetic guides accelerated their journey from the bench to the clinic, and their experience in the cell and gene therapy space.

]]> Synthego false No 2004 43 full Dina Simkin Breaks Down Epilepsy Cell Modeling Dina Simkin Breaks Down Epilepsy Cell Modeling https://crisprcuts.podbean.com/e/dina-simkin-breaks-down-epilepsy-cell-modeling/ https://crisprcuts.podbean.com/e/dina-simkin-breaks-down-epilepsy-cell-modeling/#comments Tue, 16 May 2023 05:00:00 -0700 crisprcuts.podbean.com/4a192e8c-7b37-3086-b342-cd58cf8d3301 Dina Simkin, Professor of Neurology at Northwestern University, joins us in this episode of CRISPR Cuts. Dr. Simkin talks about her path to becoming a researcher, art, and the importance of patient and isogenic iPSC models to study genetically linked forms of epilepsies.

]]> Dina Simkin, Professor of Neurology at Northwestern University, joins us in this episode of CRISPR Cuts. Dr. Simkin talks about her path to becoming a researcher, art, and the importance of patient and isogenic iPSC models to study genetically linked forms of epilepsies.

]]> Synthego false No 1644 41 full Sunil Sharma and Raffaella Soldi Talk CRISPR For Unbiased Drug Screening for Rare Pediatric Cancers Sunil Sharma and Raffaella Soldi Talk CRISPR For Unbiased Drug Screening for Rare Pediatric Cancers https://crisprcuts.podbean.com/e/sunil-sharma-and-raffaella-soldi-talk-crispr-for-unbiased-drug-screening-for-rare-pediatric-cancers/ https://crisprcuts.podbean.com/e/sunil-sharma-and-raffaella-soldi-talk-crispr-for-unbiased-drug-screening-for-rare-pediatric-cancers/#comments Mon, 24 Apr 2023 16:18:39 -0700 crisprcuts.podbean.com/735cf1ec-1bcd-363e-b83b-9d5fba765af9 Dr. Sunil Sharma and Dr. Raffaella Soldi of the Translational Genomics Research Institute chat about using CRISPR arrayed screens to identify novel drug targets for Ewing's Sarcoma, outlooks for the future of cancer therapies, and the Arizona heat.

]]> Dr. Sunil Sharma and Dr. Raffaella Soldi of the Translational Genomics Research Institute chat about using CRISPR arrayed screens to identify novel drug targets for Ewing's Sarcoma, outlooks for the future of cancer therapies, and the Arizona heat.

]]> Synthego false No 1483 42 full Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases https://crisprcuts.podbean.com/e/stephanie-cherqui-discusses-clinical-development-of-crispr-therapies-for-rare-diseases/ https://crisprcuts.podbean.com/e/stephanie-cherqui-discusses-clinical-development-of-crispr-therapies-for-rare-diseases/#comments Mon, 20 Mar 2023 04:00:00 -0700 crisprcuts.podbean.com/3d669acf-71cf-3ac6-8927-802e85e44d2a Professor Stephanie Cherqui, UCSD, has worked on the development of cell therapies for two rare genetic diseases, cystinosis and Friedreich’s ataxia. In this interview, Dr. Cherqui chats about her experience working on rare diseases, developing a CRISPR-edited therapy for Friedreich's ataxia, navigating regulatory challenges in cell and gene therapies, and more.

]]> Professor Stephanie Cherqui, UCSD, has worked on the development of cell therapies for two rare genetic diseases, cystinosis and Friedreich’s ataxia. In this interview, Dr. Cherqui chats about her experience working on rare diseases, developing a CRISPR-edited therapy for Friedreich's ataxia, navigating regulatory challenges in cell and gene therapies, and more.

]]> Synthego false No 1227 40 full Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy https://crisprcuts.podbean.com/e/christian-groendahl-on-pioneering-a-crispr-based-microbial-gene-therapy/ https://crisprcuts.podbean.com/e/christian-groendahl-on-pioneering-a-crispr-based-microbial-gene-therapy/#comments Mon, 05 Dec 2022 14:07:18 -0800 crisprcuts.podbean.com/8e787d41-6b4a-3b44-a4ec-e7940c7b9e85 Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up.

]]> Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up.

]]> Synthego false No 1751 39 full Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics https://crisprcuts.podbean.com/e/bryan-dechairo-envisions-an-accessible-future-for-crispr-diagnostics/ https://crisprcuts.podbean.com/e/bryan-dechairo-envisions-an-accessible-future-for-crispr-diagnostics/#comments Tue, 06 Sep 2022 05:00:00 -0700 crisprcuts.podbean.com/8a3b6fd4-8743-3a4a-96f3-3b3c38cd6cac In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. 

]]> In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. 

]]> Synthego false No 2129 38 full Ayal Hendel Talks About CRISPR in Bubble Boy Disease Ayal Hendel Talks About CRISPR in Bubble Boy Disease https://crisprcuts.podbean.com/e/ayal-hendel-talks-about-crispr-in-bubble-boy-disease/ https://crisprcuts.podbean.com/e/ayal-hendel-talks-about-crispr-in-bubble-boy-disease/#comments Tue, 07 Jun 2022 13:02:27 -0700 crisprcuts.podbean.com/cd92c93f-c9e4-3fb4-82cc-793f9856f07f Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the recent CRISPR advancements and his work on the bubble boy disease.

]]> Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the recent CRISPR advancements and his work on the bubble boy disease.

]]> Synthego false No 2146 37 full Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial https://crisprcuts.podbean.com/e/jimi-olaghere-opens-up-about-his-sickle-cell-disease-and-crispr-trial/ https://crisprcuts.podbean.com/e/jimi-olaghere-opens-up-about-his-sickle-cell-disease-and-crispr-trial/#comments Thu, 05 May 2022 05:00:00 -0700 crisprcuts.podbean.com/fa8fa96b-9965-3f58-aa8f-484c2bf47160 Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Jimi's journey in this episode. 

]]> Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Jimi's journey in this episode. 

]]> Synthego false No 2399 36 full TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials https://crisprcuts.podbean.com/e/tj-cradick-speaks-about-their-hiv-crispr-therapy-in-trials/ https://crisprcuts.podbean.com/e/tj-cradick-speaks-about-their-hiv-crispr-therapy-in-trials/#comments Thu, 31 Mar 2022 04:00:00 -0700 crisprcuts.podbean.com/7f85c8fa-3295-3e6c-9c48-a486986e69c7 TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. 

]]> TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. 

]]> Synthego false No 1420 35 full Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients https://crisprcuts.podbean.com/e/bryce-olson-relays-his-experience-on-personalized-therapies-for-cancer-patients/ https://crisprcuts.podbean.com/e/bryce-olson-relays-his-experience-on-personalized-therapies-for-cancer-patients/#comments Tue, 15 Mar 2022 11:19:52 -0700 crisprcuts.podbean.com/e8b62e61-c9c0-3cf4-b5d6-6a9b2e7df79e After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first time on our podcast through Bryce's narration of his experience and pursuit of next generation cell and gene therapies. 

]]> After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first time on our podcast through Bryce's narration of his experience and pursuit of next generation cell and gene therapies. 

]]> Synthego false No 2557 34 full Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells https://crisprcuts.podbean.com/e/neville-sanjana-discusses-ways-to-enhance-crispr-cas13-knockdown-in-human-cells/ https://crisprcuts.podbean.com/e/neville-sanjana-discusses-ways-to-enhance-crispr-cas13-knockdown-in-human-cells/#comments Fri, 28 Jan 2022 05:00:00 -0800 crisprcuts.podbean.com/0da4a195-9cbb-3ede-ba3d-02d523e11c16 In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells.

]]> In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells.

]]> Synthego false No 1972 33 full Kiana Aran Chats About her Nature Award and New Non-Profit Kiana Aran Chats About her Nature Award and New Non-Profit https://crisprcuts.podbean.com/e/kiana-aran-chats-about-her-nature-award-and-new-non-profit/ https://crisprcuts.podbean.com/e/kiana-aran-chats-about-her-nature-award-and-new-non-profit/#comments Mon, 15 Nov 2021 13:54:59 -0800 crisprcuts.podbean.com/421083d2-f9ac-3d66-8397-ee5e0a0d0227 In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and award winner, her early days and scientific journey, and the launch of her new non-profit, Aran Nebula.

]]> In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and award winner, her early days and scientific journey, and the launch of her new non-profit, Aran Nebula.

]]> Synthego false No 2469 32 full 6 Women CRISPR Leaders Get Candid About Their Journeys to the Top 6 Women CRISPR Leaders Get Candid About Their Journeys to the Top https://crisprcuts.podbean.com/e/6-women-crispr-leaders-get-candid-about-their-journeys-to-the-top/ https://crisprcuts.podbean.com/e/6-women-crispr-leaders-get-candid-about-their-journeys-to-the-top/#comments Thu, 28 Oct 2021 08:36:19 -0700 crisprcuts.podbean.com/9bf4d32d-1a92-3fe4-8497-eaa66cd42f09 We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. 

Tune in to this episode for a candid and honest discussion on a broad range of topics, including their experiences as women of color, life as working moms, adjusting in male-dominated fields, experiences being part of the LGBTQIA community, and the role of mentors in professional development.

]]> We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. 

Tune in to this episode for a candid and honest discussion on a broad range of topics, including their experiences as women of color, life as working moms, adjusting in male-dominated fields, experiences being part of the LGBTQIA community, and the role of mentors in professional development.

]]> Synthego false No 3764 31 full Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR https://crisprcuts.podbean.com/e/jesse-boehm-discusses-tackling-rare-cancers-using-crispr/ https://crisprcuts.podbean.com/e/jesse-boehm-discusses-tackling-rare-cancers-using-crispr/#comments Wed, 28 Jul 2021 05:00:00 -0700 crisprcuts.podbean.com/3bc05d73-772c-36ae-9fc6-f49abd4d28d3 In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transforming cancer research.

]]> In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transforming cancer research.

]]> Synthego false No 1835 30 full NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling https://crisprcuts.podbean.com/e/nih-scientists-discuss-the-indi-project-for-alzheimers-disease-modeling/ https://crisprcuts.podbean.com/e/nih-scientists-discuss-the-indi-project-for-alzheimers-disease-modeling/#comments Sun, 13 Jun 2021 17:25:14 -0700 crisprcuts.podbean.com/3a116091-4503-3f03-b0d3-197e64437dce The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at the NIH, talk about the inception of the iNDI project, the challenges and opportunities, and the future of neurodegenerative research. 

 

]]> The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at the NIH, talk about the inception of the iNDI project, the challenges and opportunities, and the future of neurodegenerative research. 

 

]]> Synthego false No 2234 29 full Joe Miano Talks About Prime Editing in Mice Joe Miano Talks About Prime Editing in Mice https://crisprcuts.podbean.com/e/joe-miano-talks-about-prime-editing-in-mice/ https://crisprcuts.podbean.com/e/joe-miano-talks-about-prime-editing-in-mice/#comments Wed, 26 May 2021 08:54:26 -0700 crisprcuts.podbean.com/7becbbf3-e12a-336e-8d86-804d8f2f2ad0 Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at the Augusta University in Georgia, talks about their collaborative work comparing traditional CRISPR-mediated homology-directed repair with prime editing in mice. 

 

]]> Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at the Augusta University in Georgia, talks about their collaborative work comparing traditional CRISPR-mediated homology-directed repair with prime editing in mice. 

 

]]> Synthego false No 1181 28 full IGI Researchers Are Using CRISPR to Reduce Cyanide in Cassava IGI Researchers Are Using CRISPR to Reduce Cyanide in Cassava https://crisprcuts.podbean.com/e/igi-researchers-are-using-crispr-to-reduce-cyanide-in-cassava/ https://crisprcuts.podbean.com/e/igi-researchers-are-using-crispr-to-reduce-cyanide-in-cassava/#comments Wed, 28 Apr 2021 05:00:00 -0700 crisprcuts.podbean.com/dad72a15-86db-3668-8335-c0d157240f6e Did you know cassava can cause cyanide poisoning if it is not processed correctly and consumed with a protein-poor diet? In this episode, we chat with IGI researchers, Jess Lyons and Michael Gomez about their work on using CRISPR to reduce cyanide in cassava and improve its food safety.

]]> Did you know cassava can cause cyanide poisoning if it is not processed correctly and consumed with a protein-poor diet? In this episode, we chat with IGI researchers, Jess Lyons and Michael Gomez about their work on using CRISPR to reduce cyanide in cassava and improve its food safety.

]]> Synthego false No 1590 27 full Kevin Davies Chats About His Latest Book "Editing Humanity" Kevin Davies Chats About His Latest Book "Editing Humanity" https://crisprcuts.podbean.com/e/kevin-davies-chats-about-his-latest-book-editing-humanity/ https://crisprcuts.podbean.com/e/kevin-davies-chats-about-his-latest-book-editing-humanity/#comments Tue, 30 Mar 2021 14:25:35 -0700 crisprcuts.podbean.com/4be91204-a044-3605-9b2a-dfc5f5a76e12 Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing." In this episode, Kevin discusses his motivation for the book, along with some behind-the-scenes stories when writing this timely literature piece.

]]> Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing." In this episode, Kevin discusses his motivation for the book, along with some behind-the-scenes stories when writing this timely literature piece.

]]> Synthego false No 1933 26 full Michael Friend Advocates For Diversity in CRISPR Michael Friend Advocates For Diversity in CRISPR https://crisprcuts.podbean.com/e/michael-friend-advocates-for-diversity-in-crispr/ https://crisprcuts.podbean.com/e/michael-friend-advocates-for-diversity-in-crispr/#comments Tue, 23 Feb 2021 23:10:28 -0800 crisprcuts.podbean.com/5f9e60c8-b9ce-3558-a032-86e7d841ce1c In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists.

]]> In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists.

]]> Synthego false No 1132 25 full CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans https://crisprcuts.podbean.com/e/crispr-2020-review-and-2021-forecast-an-executive-take/ https://crisprcuts.podbean.com/e/crispr-2020-review-and-2021-forecast-an-executive-take/#comments Tue, 12 Jan 2021 09:00:00 -0800 crisprcuts.podbean.com/638383d9-3988-3fe2-975d-85c6a12e4c75 In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. 

]]> In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. 

]]> Synthego false No 1069 24 full CRISPR Office Hours with Hamid Ghanadaan CRISPR Office Hours with Hamid Ghanadaan https://crisprcuts.podbean.com/e/crispr-office-hours-with-hamid-ghanadaan/ https://crisprcuts.podbean.com/e/crispr-office-hours-with-hamid-ghanadaan/#comments Wed, 20 May 2020 04:00:00 -0700 crisprcuts.podbean.com/32e92e0b-ab55-5ac7-aa73-929703009504 The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scientists.

]]> The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scientists.

]]> 1000 scientists.]]> Synthego false No 2158 23 full Ryan Pawell Talks About Indee Labs’ CRISPR Delivery Technology for Affordable Immunotherapies Ryan Pawell Talks About Indee Labs’ CRISPR Delivery Technology for Affordable Immunotherapies https://crisprcuts.podbean.com/e/ryan-pawell-talks-about-indee-labs-crispr-delivery-technology-for-affordable-immunotherapies/ https://crisprcuts.podbean.com/e/ryan-pawell-talks-about-indee-labs-crispr-delivery-technology-for-affordable-immunotherapies/#comments Thu, 07 May 2020 05:00:00 -0700 crisprcuts.podbean.com/fa2fb678-7898-569b-a182-bd0136ad40fa The mission of Indee Labs, a Berkeley biotech, is to deliver CRISPR reagents into cells using microfluidics for developing affordable cell and gene therapies in the future. We interviewed Ryan Pawell, Founder and CEO of Indee Labs, about the concept of using microfluidics for CRISPR delivery, their mission and ongoing projects, and the convergence of engineering and biology for building scalable platforms.

]]> The mission of Indee Labs, a Berkeley biotech, is to deliver CRISPR reagents into cells using microfluidics for developing affordable cell and gene therapies in the future. We interviewed Ryan Pawell, Founder and CEO of Indee Labs, about the concept of using microfluidics for CRISPR delivery, their mission and ongoing projects, and the convergence of engineering and biology for building scalable platforms.

]]> Synthego false No 779 22 full Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature https://crisprcuts.podbean.com/e/making-of-a-crispr-film-behind-the-scenes-with-producers-of-human-nature/ https://crisprcuts.podbean.com/e/making-of-a-crispr-film-behind-the-scenes-with-producers-of-human-nature/#comments Wed, 22 Apr 2020 19:13:39 -0700 crisprcuts.podbean.com/e6e3c3e5-36da-5bab-82b9-1b48877c3627 What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film.

]]> What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film.

]]> Synthego false No 2253 21 full Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller https://crisprcuts.podbean.com/e/ins-and-outs-of-a-crispr-genome-engineering-core-facility-a-chat-with-shondra-miller/ https://crisprcuts.podbean.com/e/ins-and-outs-of-a-crispr-genome-engineering-core-facility-a-chat-with-shondra-miller/#comments Tue, 28 Jan 2020 06:00:00 -0800 crisprcuts.podbean.com/1a4c412b-651d-5d05-842b-6f5174787bfd Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this podcast episode.

]]> Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this podcast episode.

]]> Synthego false No 613 20 full The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes https://crisprcuts.podbean.com/e/the-potential-of-crispr-editing-in-stem-cells-an-interview-with-bill-skarnes/ https://crisprcuts.podbean.com/e/the-potential-of-crispr-editing-in-stem-cells-an-interview-with-bill-skarnes/#comments Wed, 13 Nov 2019 13:39:57 -0800 crisprcuts.podbean.com/the-potential-of-crispr-editing-in-stem-cells-an-interview-with-bill-skarnes-f348f8ea3e14ce7bb6b58c9d36f1ce6a Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. 

]]> Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. 

]]> Synthego false No 786 19 full CRISPR in Fungi: An Interview with Rebecca Shapiro CRISPR in Fungi: An Interview with Rebecca Shapiro https://crisprcuts.podbean.com/e/crispr-in-fungi-an-interview-with-rebecca-shapiro/ https://crisprcuts.podbean.com/e/crispr-in-fungi-an-interview-with-rebecca-shapiro/#comments Wed, 04 Sep 2019 08:37:03 -0700 crisprcuts.podbean.com/crispr-in-fungi-an-interview-with-rebecca-shapiro-2392c5348d279e6a4f7cdd85ba90d359 Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interactions and developing ways for treating fungal biofilms.

]]> Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interactions and developing ways for treating fungal biofilms.

]]> Synthego false No 1087 18 full Paul Dabrowski Gets Candid About the Past, Present, and Future of Synthego Paul Dabrowski Gets Candid About the Past, Present, and Future of Synthego https://crisprcuts.podbean.com/e/paul-dabrowski-gets-candid-about-the-past-present-and-future-of-synthego/ https://crisprcuts.podbean.com/e/paul-dabrowski-gets-candid-about-the-past-present-and-future-of-synthego/#comments Wed, 07 Aug 2019 10:55:32 -0700 crisprcuts.podbean.com/paul-dabrowski-gets-candid-about-the-past-present-and-future-of-synthego-c88c2b2158194af1b892547b150c08b7 In this interview, Paul Dabrowski, CEO of Synthego, talks about how Synthego got started, his mantra behind leading the company, and future directions. He also offers insights into Synthego’s unique capabilities⁠—the powerful combination of engineering and biology that enable scaling.

]]> In this interview, Paul Dabrowski, CEO of Synthego, talks about how Synthego got started, his mantra behind leading the company, and future directions. He also offers insights into Synthego’s unique capabilities⁠—the powerful combination of engineering and biology that enable scaling.

]]> Synthego false No 1335 17 full Dana Foss is Solving the CRISPR Delivery Problem to Advance Therapeutics Dana Foss is Solving the CRISPR Delivery Problem to Advance Therapeutics https://crisprcuts.podbean.com/e/dana-foss-is-solving-the-crispr-delivery-problem-to-advance-therapeutics/ https://crisprcuts.podbean.com/e/dana-foss-is-solving-the-crispr-delivery-problem-to-advance-therapeutics/#comments Wed, 22 May 2019 11:47:34 -0700 crisprcuts.podbean.com/dana-foss-is-solving-the-crispr-delivery-problem-to-advance-therapeutics-a20f0aa6d40d8654e409c9e3205cd200 CRISPR has great potential in therapeutics, but CRISPR delivery in vivo remains a challenge. Researcher Dana Foss discusses her lab’s novel approach for specific delivery of CRISPR components in cells and tissues.

]]> CRISPR has great potential in therapeutics, but CRISPR delivery in vivo remains a challenge. Researcher Dana Foss discusses her lab’s novel approach for specific delivery of CRISPR components in cells and tissues.

]]> Synthego false No 975 16 full SHERLOCK Founders Crack the Case of CRISPR Diagnostics SHERLOCK Founders Crack the Case of CRISPR Diagnostics https://crisprcuts.podbean.com/e/crispr-cuts-with-sherlock-researchers/ https://crisprcuts.podbean.com/e/crispr-cuts-with-sherlock-researchers/#comments Wed, 08 May 2019 15:34:57 -0700 crisprcuts.podbean.com/crispr-cuts-with-sherlock-researchers-3a943bbed5e7f84d688607271c289079 CRISPR is going beyond gene editing into a new area: diagnostics. Omar Abudayyeh and Jonathan Gootenberg, co-founders of SHERLOCK Biosciences, talk about the present advances and future of CRISPR diagnostics. 

]]> CRISPR is going beyond gene editing into a new area: diagnostics. Omar Abudayyeh and Jonathan Gootenberg, co-founders of SHERLOCK Biosciences, talk about the present advances and future of CRISPR diagnostics. 

]]> Synthego false No 1264 15 full Kiana Aran Chats About Her New Biosensor: CRISPR-Chip Kiana Aran Chats About Her New Biosensor: CRISPR-Chip https://crisprcuts.podbean.com/e/kiana-aran-explains-her-new-biosensor-crispr-chip/ https://crisprcuts.podbean.com/e/kiana-aran-explains-her-new-biosensor-crispr-chip/#comments Thu, 18 Apr 2019 13:31:29 -0700 crisprcuts.podbean.com/kiana-aran-explains-her-new-biosensor-crispr-chip-cb7ab836de77c1461186b7b9fa6a47ca Kiana Aran, a biomedical engineering expert, talks about her research on CRISPR-Chip, a new biosensor that combines CRISPR & electronics to detect specific genes in genomic DNA.

]]> Kiana Aran, a biomedical engineering expert, talks about her research on CRISPR-Chip, a new biosensor that combines CRISPR & electronics to detect specific genes in genomic DNA.

]]> Synthego false No 1138 14 full How the Innovative Genomics Institute is Helping People Understand CRISPR How the Innovative Genomics Institute is Helping People Understand CRISPR https://crisprcuts.podbean.com/e/how-the-innovative-genomics-institute-is-helping-people-understand-crispr/ https://crisprcuts.podbean.com/e/how-the-innovative-genomics-institute-is-helping-people-understand-crispr/#comments Tue, 19 Mar 2019 11:56:09 -0700 crisprcuts.podbean.com/how-the-innovative-genomics-institute-is-helping-people-understand-crispr-fbc2c18c7a555565d872c80c1a8cb13d Megan Hochstrasser, Science Communications Manager at the Innovative Genomics Institute, talks about the importance of CRISPR science communication and the ongoing efforts at IGI to help people understand this genome engineering tool.

]]> Megan Hochstrasser, Science Communications Manager at the Innovative Genomics Institute, talks about the importance of CRISPR science communication and the ongoing efforts at IGI to help people understand this genome engineering tool.

]]> Synthego false No 1412 13 full Improving Targeted Delivery to Enhance Personalized Medicine Improving Targeted Delivery to Enhance Personalized Medicine https://crisprcuts.podbean.com/e/improving-targeted-delivery-to-enhance-personalized-medicine/ https://crisprcuts.podbean.com/e/improving-targeted-delivery-to-enhance-personalized-medicine/#comments Tue, 26 Feb 2019 09:37:06 -0800 crisprcuts.podbean.com/improving-targeted-delivery-to-enhance-personalized-medicine-92c4fefb8141612935735434dc0298b8 Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public.

]]> Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public.

]]> Synthego false No 1677 12 full Alex Philippidis Reviews Trends in Biopharma & Biotech Market Alex Philippidis Reviews Trends in Biopharma & Biotech Market https://crisprcuts.podbean.com/e/alex-philippidis-reviews-biopharma-market-trends/ https://crisprcuts.podbean.com/e/alex-philippidis-reviews-biopharma-market-trends/#comments Thu, 07 Feb 2019 09:05:20 -0800 crisprcuts.podbean.com/alex-philippidis-reviews-biopharma-market-trends-da8cb24e9a18110d988d5da604bd8f41 Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise more money and the world changes around them.

]]> Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise more money and the world changes around them.

]]> Synthego false No 1674 11 full Avery Posey Discusses CAR T Cell Cancer Therapies Avery Posey Discusses CAR T Cell Cancer Therapies https://crisprcuts.podbean.com/e/avery-posey-discusses-car-t-cell-cancer-therapies/ https://crisprcuts.podbean.com/e/avery-posey-discusses-car-t-cell-cancer-therapies/#comments Thu, 24 Jan 2019 08:22:52 -0800 crisprcuts.podbean.com/avery-posey-discusses-car-t-cell-cancer-therapies-0c46ab2a7eacd3438a538947085eb583 Dr. Avery Posey is leading the charge on CAR T cell therapy research to bring this technology to cancer patients as soon as possible. Learn how CAR T works, what stage it’s in now, and how it will help revolutionize the treatment of cancer.

 

]]> Dr. Avery Posey is leading the charge on CAR T cell therapy research to bring this technology to cancer patients as soon as possible. Learn how CAR T works, what stage it’s in now, and how it will help revolutionize the treatment of cancer.

 

]]> Synthego false No 1512 10 full Trevor Martin Discusses How CRISPR is Changing Diagnostics Trevor Martin Discusses How CRISPR is Changing Diagnostics https://crisprcuts.podbean.com/e/trevor-martin-discusses-how-crispr-diagnostics-are-changing-medicine/ https://crisprcuts.podbean.com/e/trevor-martin-discusses-how-crispr-diagnostics-are-changing-medicine/#comments Thu, 10 Jan 2019 09:42:07 -0800 crisprcuts.podbean.com/trevor-martin-discusses-how-crispr-diagnostics-are-changing-medicine-13ebe819df88fb3b9f767b16cb19de3a Trevor Martin, CEO of Mammoth Biosciences, talks about the science behind CRISPR diagnostics, and what Mammoth is doing to bring it to consumers in the next decade.

]]> Trevor Martin, CEO of Mammoth Biosciences, talks about the science behind CRISPR diagnostics, and what Mammoth is doing to bring it to consumers in the next decade.

]]> Synthego false No 1617 9 full CRISPR for Curious Minds CRISPR for Curious Minds https://crisprcuts.podbean.com/e/crispr-cuts-meets-curiosity-podcast/ https://crisprcuts.podbean.com/e/crispr-cuts-meets-curiosity-podcast/#comments Thu, 13 Dec 2018 20:28:46 -0800 crisprcuts.podbean.com/crispr-cuts-meets-curiosity-podcast-634862e9f690e62e1e7cb8d9109a0828 In this Holiday-special mash-up episode, CRISPR Cuts teams up with Curiosity podcast to discuss the ins and outs of CRISPR. Gear up, it's going to be a fun ride!

]]> In this Holiday-special mash-up episode, CRISPR Cuts teams up with Curiosity podcast to discuss the ins and outs of CRISPR. Gear up, it's going to be a fun ride!

]]> Synthego false No 2461 8 full Andrew Porterfield Discusses CRISPR in the Grocery Store Andrew Porterfield Discusses CRISPR in the Grocery Store https://crisprcuts.podbean.com/e/andrew-porterfield/ https://crisprcuts.podbean.com/e/andrew-porterfield/#comments Wed, 21 Nov 2018 19:28:51 -0800 crisprcuts.podbean.com/andrew-porterfield-fcd9c633bba1181109fb84fedaec51b4 Andrew Porterfield is a scientific marketing consultant, science journalist, and all around science communicator. We caught up with Andrew to discuss the latest news about how CRISPR is impacting the agriculture industry and how the various regulatory decisions related to this technology may shape its use and adoption in different parts of the world.

]]> Andrew Porterfield is a scientific marketing consultant, science journalist, and all around science communicator. We caught up with Andrew to discuss the latest news about how CRISPR is impacting the agriculture industry and how the various regulatory decisions related to this technology may shape its use and adoption in different parts of the world.

]]> Synthego false No 2075 1 7 full Alison Van Eenennaam Edits Cattle Using CRISPR Alison Van Eenennaam Edits Cattle Using CRISPR https://crisprcuts.podbean.com/e/alison-van-eenennaam-phd/ https://crisprcuts.podbean.com/e/alison-van-eenennaam-phd/#comments Fri, 09 Nov 2018 15:05:38 -0800 crisprcuts.podbean.com/alison-van-eenennaam-phd-c3eb253eec3ecfb7cec21791636d9596 Alison Van Eenennaam is a geneticist at UC Davis, primarily interested in using CRISPR and other DNA-based biotechnologies in cattle production and agricultural systems. Learn about her exciting projects, ranging from "All Boys" cattle to hornless dairy cows, and the technical difficulties of working with large mammals in this episode.

]]> Alison Van Eenennaam is a geneticist at UC Davis, primarily interested in using CRISPR and other DNA-based biotechnologies in cattle production and agricultural systems. Learn about her exciting projects, ranging from "All Boys" cattle to hornless dairy cows, and the technical difficulties of working with large mammals in this episode.

]]> Synthego false No 1556 1 6 full CRISPR in Gene Drives: Experts Opine CRISPR in Gene Drives: Experts Opine https://crisprcuts.podbean.com/e/crispr-cuts-covers-gene-drives/ https://crisprcuts.podbean.com/e/crispr-cuts-covers-gene-drives/#comments Tue, 23 Oct 2018 13:11:07 -0700 crisprcuts.podbean.com/crispr-cuts-covers-gene-drives-49897368135fc0496fcc5ee69e1d8366 Gene drives have frequently been in the news in the past few years. In this episode, we discuss what exactly gene drives are, their applications, and how scientists are ensuring that they are used responsibly. Tune in to hear what researchers Anna Buchman from UCSD and Kevin Esvelt from MIT had to say.

]]> Gene drives have frequently been in the news in the past few years. In this episode, we discuss what exactly gene drives are, their applications, and how scientists are ensuring that they are used responsibly. Tune in to hear what researchers Anna Buchman from UCSD and Kevin Esvelt from MIT had to say.

]]> Synthego false No 657 1 5 full Knockout Cell Pools Are Simplifying CRISPR Experiments Knockout Cell Pools Are Simplifying CRISPR Experiments https://crisprcuts.podbean.com/e/crispr-cuts-with-ania-wronski/ https://crisprcuts.podbean.com/e/crispr-cuts-with-ania-wronski/#comments Wed, 03 Oct 2018 23:36:34 -0700 crisprcuts.podbean.com/crispr-cuts-with-ania-wronski-7d08ea1a246019b866efbb1bd86c31d5 Dr. Ania Wronski, Product Manager for the Engineered Cells portfolio at Synthego, discusses how their new engineered cells products are enabling CRISPR access to researchers worldwide. Learn about the different ways in which researchers use knockout cell pools & their advantages over RNAi.

]]> Dr. Ania Wronski, Product Manager for the Engineered Cells portfolio at Synthego, discusses how their new engineered cells products are enabling CRISPR access to researchers worldwide. Learn about the different ways in which researchers use knockout cell pools & their advantages over RNAi.

]]> Synthego false No 1235 1 4 full CRISPR Edited Animals & Their Applications CRISPR Edited Animals & Their Applications https://crisprcuts.podbean.com/e/transgenic-animals/ https://crisprcuts.podbean.com/e/transgenic-animals/#comments Tue, 18 Sep 2018 09:09:37 -0700 crisprcuts.podbean.com/transgenic-animals-0d1a92e51fb0e2922c5fbdaad84ce89a What do you think of when you hear the term "transgenic animal"? The hippogriff from Harry Potter? A mouse model to study diabetes? Kevin and Minu discuss what transgenic animals are, how they are used in research, and how CRISPR has changed the transgenic game. After listening, head over to The Bench blog to read more about CRISPR and transgenic animals.

]]> What do you think of when you hear the term "transgenic animal"? The hippogriff from Harry Potter? A mouse model to study diabetes? Kevin and Minu discuss what transgenic animals are, how they are used in research, and how CRISPR has changed the transgenic game. After listening, head over to The Bench blog to read more about CRISPR and transgenic animals.

]]> Synthego false No 648 1 3 full Carl Zimmer Discusses Heredity, Genomics, and CRISPR Carl Zimmer Discusses Heredity, Genomics, and CRISPR https://crisprcuts.podbean.com/e/carl-zimmer/ https://crisprcuts.podbean.com/e/carl-zimmer/#comments Wed, 05 Sep 2018 12:11:39 -0700 crisprcuts.podbean.com/carl-zimmer-9913ae8f42aefaf0468fd89c2fb6c4a5 It's not every day you get to meet one of your idols! Minu and Kevin caught up with Carl Zimmer, an award-winning New York Times columnist and science journalist. Minu chatted with Zimmer and got a rare behind-the-scenes glimpse into his latest book "She Has Her Mother's Laugh" and discussed his views on CRISPR and genomics. 

]]> It's not every day you get to meet one of your idols! Minu and Kevin caught up with Carl Zimmer, an award-winning New York Times columnist and science journalist. Minu chatted with Zimmer and got a rare behind-the-scenes glimpse into his latest book "She Has Her Mother's Laugh" and discussed his views on CRISPR and genomics. 

]]> Synthego false No 696 1 2 full Reed Kelso Strives to Enable CRISPR Access For All Scientists Reed Kelso Strives to Enable CRISPR Access For All Scientists https://crisprcuts.podbean.com/e/reed-kelso-phd/ https://crisprcuts.podbean.com/e/reed-kelso-phd/#comments Fri, 24 Aug 2018 13:37:13 -0700 crisprcuts.podbean.com/reed-kelso-phd-aa0bd49cf9f1d29fabe5befb8419f317 Reed Kelso, Head of Cell Engineering Research and Applications at Synthego, is a bio-wizard. In this episode, Kevin & Minu catch up with Reed about his role at Synthego and the day-to-day operations at the fast paced start-up. Reed talks about the revolutionary engineered cells products that he and his team recently launched & the hard work behind this amazing achievement. He also speculates about the future applications of CRISPR; his bets are on CRISPR making a massive splash in agriculture!

]]> Reed Kelso, Head of Cell Engineering Research and Applications at Synthego, is a bio-wizard. In this episode, Kevin & Minu catch up with Reed about his role at Synthego and the day-to-day operations at the fast paced start-up. Reed talks about the revolutionary engineered cells products that he and his team recently launched & the hard work behind this amazing achievement. He also speculates about the future applications of CRISPR; his bets are on CRISPR making a massive splash in agriculture!

]]> Synthego false No 954 1 1 full